Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

The benzenesulfoamide T0901317 (N-(2,2,2-trifluoroethyl)-N-(4-( 2,2,2-trifluoro-1-hydroxy-1-(trifluorome thyl)ethyl phenyl -benzenesulfonamide is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Kumar, N.
  • Solt, Laura A.
  • Conkright, J. J.
  • Wang, Y. J.
  • Istrate, M. A.
  • Busby, S. A.
  • Garcia-Ordonez, R. D.
  • Burris, Thomas
  • Griffin, Patrick

publication date

  • February 2010

journal

  • Molecular Pharmacology  Journal

abstract

  • Retinoic acid receptor-related orphan receptors (RORs) regulate a variety of physiological processes including hepatic gluconeogenesis, lipid metabolism, circadian rhythm, and immune function. Here we present the first high-affinity synthetic ligand for both RORalpha and RORgamma. In a screen against all 48 human nuclear receptors, the benzenesulfonamide liver X receptor (LXR) agonist N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide (T0901317) inhibited transactivation activity of RORalpha and RORgamma but not RORbeta. T0901317 was found to directly bind to RORalpha and RORgamma with high affinity (K(i) = 132 and 51 nM, respectively), resulting in the modulation of the receptor's ability to interact with transcriptional cofactor proteins. T0901317 repressed RORalpha/gamma-dependent transactivation of ROR-responsive reporter genes and in HepG2 cells reduced recruitment of steroid receptor coactivator-2 by RORalpha at an endogenous ROR target gene (G6Pase). Using small interference RNA, we demonstrate that repression of the gluconeogenic enzyme glucose-6-phosphatase in HepG2 cells by T0901317 is ROR-dependent and is not due to the compound's LXR activity. In summary, T0901317 represents a novel chemical probe to examine RORalpha/gamma function and an excellent starting point for the development of ROR selective modulators. More importantly, our results demonstrate that small molecules can be used to target the RORs for therapeutic intervention in metabolic and immune disorders.

subject areas

  • Cell Line
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Humans
  • Hydrocarbons, Fluorinated
  • Nuclear Receptor Subfamily 1, Group F, Member 1
  • Protein Binding
  • Receptors, Retinoic Acid
  • Sulfonamides
scroll to property group menus

Identity

PubMed Central ID

  • PMC2812071

International Standard Serial Number (ISSN)

  • 0026-895X

Digital Object Identifier (DOI)

  • 10.1124/mol.109.060905

PubMed ID

  • 19887649
scroll to property group menus

Additional Document Info

start page

  • 228

end page

  • 236

volume

  • 77

issue

  • 2

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support